Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

House Resolution

H.Res. 803

119th Congress

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

In Committee

Introduced:Oct 10, 2025

Primary Sponsor

John Rose

R - TN

Cosponsors

11

Quick Stats

Policy Area

Health

Summary

Urges the FDA to reevaluate the safety of mifepristone and other chemical abortion drugs, citing independent studies claiming complication rates 22 times higher than officially reported. Notes chemical abortions now account for over half of U.S. abortions.

Latest Action

Referred to the House Committee on Energy and Commerce.

AI Summary

Plain-English explanation of this bill

Urges the FDA to reevaluate the safety of mifepristone and other chemical abortion drugs, citing independent studies claiming complication rates 22 times higher than officially reported. Notes chemical abortions now account for over half of U.S. abortions.

Last updated: 12/29/2025

Key Points

Main provisions of the bill

Urges FDA safety reevaluation of chemical abortion drugs
Cites claim of 22x higher complication rate than reported
Notes chemical abortions now over half of U.S. abortions
Criticizes Obama and Biden administration access expansions
References September 2025 approval of generic mifepristone

How This Impacts Americans

Potential effects on citizens and communities

FDA would be pressured to conduct new safety review of mifepristone. Could affect availability of medication abortion if safety concerns substantiated. Resolution expresses House sense without mandating FDA action.

Policy Areas

Primary Policy Area

Health

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

803, 119th Congress (2025). "Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.". Source: Voter's Right Platform. https://votersright.org/bills/119-hres-803